SolasCure

SolasCure

Revolutionising Wound Care.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

Valuation: €0.0

round
investor

€0.0

round
*

£405k

Grant
Total Funding000k
More about SolasCure
Made with AI
Edit

SolasCure is an innovative biotech startup focused on developing advanced wound care solutions. The company's flagship product, Aurase Wound Gel, is a hydrogel that contains the proteolytic enzyme Tarumase. This enzyme is designed to facilitate the debridement process, which involves removing dead or damaged tissue from wounds. Additionally, Aurase Wound Gel helps reduce bacterial biofilm and promotes wound bed preparation and healing. Tarumase is a recombinantly produced enzyme, meaning it is created through genetic engineering to mimic the natural protease used by larvae to break down necrotic tissue. Unlike many other proteases, Tarumase is highly effective and does not cause allergic reactions.

SolasCure primarily serves healthcare providers, including hospitals, clinics, and wound care specialists. The company operates in the global medical device and biopharma markets, with a particular focus on regenerative medicine. Its business model revolves around the research, development, and commercialization of its proprietary wound care products. SolasCure generates revenue through the sale of Aurase Wound Gel and potentially through partnerships and licensing agreements with other medical and biopharma companies.

The leadership team at SolasCure brings extensive experience in the medical and biotech fields. For instance, the company's CEO has a background as a surgeon and former Chief Medical Officer at Smith & Nephew, a global medical technology company. This deep sector experience, combined with a strong track record in research and development, positions SolasCure as a promising player in the wound care market.

In summary, SolasCure is dedicated to improving wound care through innovative biotechnological solutions, targeting healthcare providers and operating within the medical device and biopharma sectors. The company makes money by selling its advanced wound care products and potentially through strategic partnerships.

Keywords: wound care, biotech, hydrogel, enzyme, debridement, bacterial biofilm, healing, healthcare, medical device, regenerative medicine.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo